BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Himmel ME, Yao Y, Orban PC, Steiner TS, Levings MK. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology. 2012;136:115-122. [PMID: 22348589 DOI: 10.1111/j.1365-2567.2012.03572.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Mirabelli G, Cannarile F, Cipriani P, Giacomelli R, Gerli R. T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. Mediators Inflamm 2015;2015:243723. [PMID: 26060357 DOI: 10.1155/2015/243723] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
2 Jeffery HC, Braitch MK, Brown S, Oo YH. Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives. Front Immunol 2016;7:334. [PMID: 27656181 DOI: 10.3389/fimmu.2016.00334] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
3 Shao TY, Hsu LH, Chien CH, Chiang BL. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo. Sci Rep 2016;6:32415. [PMID: 27581189 DOI: 10.1038/srep32415] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
4 Lightner AL. Stem Cell Therapy for Inflammatory Bowel Disease. Clin Transl Gastroenterol 2017;8:e82. [PMID: 28300823 DOI: 10.1038/ctg.2017.7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Li GG, Cao YH, Run Y, Xu RX, Zheng ZD. Inhibition of CD8+ T cells and elimination of myeloid cells by CD4+  Foxp3- T regulatory type 1 cells in acute respiratory distress syndrome. Clin Exp Pharmacol Physiol 2016;43:1191-8. [PMID: 27558304 DOI: 10.1111/1440-1681.12656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Cao Y, Shen J, Ran ZH. Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature. Gastroenterol Res Pract. 2014;2014:872725. [PMID: 24799893 DOI: 10.1155/2014/872725] [Cited by in Crossref: 90] [Cited by in F6Publishing: 110] [Article Influence: 11.3] [Reference Citation Analysis]
7 Akimova T, Xiao H, Liu Y, Bhatti TR, Jiao J, Eruslanov E, Singhal S, Wang L, Han R, Zacharia K, Hancock WW, Beier UH. Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3+ T-regulatory cells. Mucosal Immunol. 2014;7:1209-1220. [PMID: 24549276 DOI: 10.1038/mi.2014.10] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
8 Steinmeyer S, Howsmon DP, Alaniz RC, Hahn J, Jayaraman A. Empirical modeling of T cell activation predicts interplay of host cytokines and bacterial indole. Biotechnol Bioeng 2017;114:2660-7. [PMID: 28667749 DOI: 10.1002/bit.26371] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
9 Grzywacz K, Butcher J, Romain G, Li J, Stintzi A. The impact of probiotics and lactoferrin supplementation on piglet gastrointestinal microbial communities. Biometals 2019;32:533-43. [PMID: 31041632 DOI: 10.1007/s10534-019-00195-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Assa A, Butcher J, Li J, Elkadri A, Sherman PM, Muise AM, Stintzi A, Mack D. Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease. Inflamm Bowel Dis. 2016;22:1533-1539. [PMID: 27271491 DOI: 10.1097/mib.0000000000000776] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
11 Bhaumik S, Mickael ME, Moran M, Spell M, Basu R. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells. J Immunol 2021;207:2027-38. [PMID: 34518282 DOI: 10.4049/jimmunol.2100175] [Reference Citation Analysis]
12 Langhorst J, Frede A, Knott M, Pastille E, Buer J, Dobos GJ, Westendorf AM. Distinct Kinetics in the Frequency of Peripheral CD4+ T Cells in Patients with Ulcerative Colitis Experiencing a Flare during Treatment with Mesalazine or with a Herbal Preparation of Myrrh, Chamomile, and Coffee Charcoal. PLoS One. 2014;9:e104257. [PMID: 25144293 DOI: 10.1371/journal.pone.0104257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Ciccocioppo R, Cangemi GC, Kruzliak P, Corazza GR. Concise Review: Cellular Therapies: The Potential to Regenerate and Restore Tolerance in Immune-Mediated Intestinal Diseases. Stem Cells 2016;34:1474-86. [PMID: 27016400 DOI: 10.1002/stem.2367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
14 Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019;94:155-165. [PMID: 30611442 DOI: 10.1016/j.mayocp.2018.09.013] [Cited by in Crossref: 141] [Cited by in F6Publishing: 131] [Article Influence: 47.0] [Reference Citation Analysis]
15 Lee SY, Lee SH, Yang EJ, Kim EK, Kim JK, Shin DY, Cho ML. Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance. PLoS One. 2015;10:e0135858. [PMID: 26360050 DOI: 10.1371/journal.pone.0135858] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 13.3] [Reference Citation Analysis]
16 Hashemi V, Farrokhi AS, Tanomand A, Babaloo Z, Hojjat-farsangi M, Anvari E, Tahoori M, Ezzeddini R, Hosseini A, Gharibi T, Ghalamfarsa G, Jadidi-niaragh F. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunology Letters 2018;204:16-22. [DOI: 10.1016/j.imlet.2018.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
17 Yin H, Li X, Zhang B, Liu T, Yuan B, Ni Q, Hu S, Gu H. Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. Immunology 2013;139:494-502. [PMID: 23480027 DOI: 10.1111/imm.12096] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
18 Li J, Ueno A, Iacucci M, Fort Gasia M, Jijon HB, Panaccione R, Kaplan GG, Beck PL, Luider J, Barkema HW, Qian J, Gui X, Ghosh S. Crossover subsets of CD4+ T lymphocytes in the intestinal lamina propria of patients with Crohn's disease and ulcerative colitis. Dig Dis Sci. 2017;62:2357-2368. [PMID: 28573508 DOI: 10.1007/s10620-017-4596-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
19 Tsai HF, Wu CS, Chen YL, Liao HJ, Chyuan IT, Hsu PN. Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis. J Mol Med (Berl). 2016;94:545-556. [PMID: 26631140 DOI: 10.1007/s00109-015-1368-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
20 Sinkoe A, Jayaraman A, Hahn J. Dynamic optimal experimental design yields marginal improvement over steady-state results for computational maximisation of regulatory T-cell induction in ex vivo culture. IET Syst Biol 2018;12:241-6. [PMID: 30472687 DOI: 10.1049/iet-syb.2018.5014] [Reference Citation Analysis]
21 Hall LS, Hall AM, Pickford W, Vickers MA, Urbaniak SJ, Barker RN. Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the RhD protein in HLA-transgenic mice. Haematologica 2014;99:588-96. [PMID: 24441145 DOI: 10.3324/haematol.2012.082081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
22 Hossein-Khannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, Kadri N, Vosough M. Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results. Hum Cell 2021;34:1289-300. [PMID: 34057700 DOI: 10.1007/s13577-021-00560-w] [Reference Citation Analysis]
23 Edward JA, Sanyal M, Le W, Soudry E, Ramakrishnan VR, Bravo DT, Nguyen AL, Zarabanda D, Kingdom TT, Hwang PH, Garrison Fathman C, Nayak JV. Selective expansion of human regulatory T cells in nasal polyps, and not adjacent tissue microenvironments, in individual patients exposed to steroids. Clin Immunol 2017;179:66-76. [PMID: 28279811 DOI: 10.1016/j.clim.2017.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
24 Sinkoe A, Hahn J. Optimal Experimental Design for Parameter Estimation of an IL-6 Signaling Model. Processes 2017;5:49. [DOI: 10.3390/pr5030049] [Cited by in Crossref: 12] [Article Influence: 2.4] [Reference Citation Analysis]
25 Azimi M, Aslani S, Mortezagholi S, Salek A, Javan MR, Rezaiemanesh A, Ghaedi M, Gholamzad M, Salehi E. Identification, Isolation, and Functional Assay of Regulatory T Cells. Immunological Investigations 2016;45:584-602. [DOI: 10.1080/08820139.2016.1193869] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
26 Liu Y, Carlsson R, Comabella M, Wang J, Kosicki M, Carrion B, Hasan M, Wu X, Montalban X, Dziegiel MH, Sellebjerg F, Sørensen PS, Helin K, Issazadeh-navikas S. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS. Nat Med 2014;20:272-82. [DOI: 10.1038/nm.3485] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 12.1] [Reference Citation Analysis]
27 Long Y, Li S, Qin J, Xie L, Gan L, Jie F, Wu Y, Li Y, Du Q. Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats. Biomed Pharmacother. 2018;105:781-788. [PMID: 29909346 DOI: 10.1016/j.biopha.2018.06.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
28 Wang H, Lu CH, Ho PC. Metabolic adaptation orchestrates tissue context-dependent behavior in regulatory T cells. Immunol Rev 2020;295:126-39. [PMID: 32147869 DOI: 10.1111/imr.12844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Zhu C, Song K, Shen Z, Quan Y, Tan B, Luo W, Wu S, Tang K, Yang Z, Wang X. Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis. Mol Med Rep 2018;17:7567-74. [PMID: 29620246 DOI: 10.3892/mmr.2018.8833] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
30 Sun P, Liu J, Li W, Xu X, Gu X, Li H, Han H, Du C, Wang H. Human endometrial regenerative cells attenuate renal ischemia reperfusion injury in mice. J Transl Med 2016;14:28. [PMID: 26822150 DOI: 10.1186/s12967-016-0782-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
31 Brandhorst G, Petrova DT, Weigand S, Eberle C, von Ahsen N, Schmitz J, Schultze FC, Raddatz D, Karaus M, Oellerich M, Walson PD. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients. World J Gastroenterol 2015; 21(11): 3325-3329 [PMID: 25805940 DOI: 10.3748/wjg.v21.i11.3325] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
32 Ranjbar R, Ghasemian M, Maniati M, Hossein Khatami S, Jamali N, Taheri-anganeh M. Gastrointestinal disorder biomarkers. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.02.013] [Reference Citation Analysis]
33 Liu Y, Zhou M, Yang M, Jin C, Song Y, Chen J, Gao M, Ai Z, Su D. Pulsatilla chinensis Saponins Ameliorate Inflammation and DSS-Induced Ulcerative Colitis in Rats by Regulating the Composition and Diversity of Intestinal Flora. Front Cell Infect Microbiol 2021;11:728929. [PMID: 34804990 DOI: 10.3389/fcimb.2021.728929] [Reference Citation Analysis]
34 Petito V, Graziani C, Lopetuso LR, Fossati M, Battaglia A, Arena V, Scannone D, Quaranta G, Quagliariello A, Del Chierico F, Putignani L, Masucci L, Sanguinetti M, Sgambato A, Gasbarrini A, Scaldaferri F. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol 2019; 25(12): 1465-1477 [PMID: 30948910 DOI: 10.3748/wjg.v25.i12.1465] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Lu S, Shi G, Xu X, Wang G, Lan X, Sun P, Li X, Zhang B, Gu X, Ichim TE, Wang H. Human endometrial regenerative cells alleviate carbon tetrachloride-induced acute liver injury in mice. J Transl Med 2016;14:300. [PMID: 27770815 DOI: 10.1186/s12967-016-1051-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
36 Zhang YY, Feng BS, Zhang H, Yang G, Jin QR, Luo XQ, Ma N, Huang QM, Yang LT, Zhang GH, Liu DB, Yu Y, Liu ZG, Zheng PY, Yang PC. Modulating oxidative stress counteracts specific antigen-induced regulatory T-cell apoptosis in mice. Eur J Immunol 2021;51:1748-61. [PMID: 33811758 DOI: 10.1002/eji.202049112] [Reference Citation Analysis]
37 Valatas V, Bamias G, Kolios G. Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues. European Journal of Pharmacology 2015;759:253-64. [DOI: 10.1016/j.ejphar.2015.03.017] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 8.0] [Reference Citation Analysis]
38 Sebode M, Peiseler M, Franke B, Schwinge D, Schoknecht T, Wortmann F, Quaas A, Petersen B, Ellinghaus E, Baron U, Olek S, Wiegard C, Weiler-normann C, Lohse AW, Herkel J, Schramm C. Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. Journal of Hepatology 2014;60:1010-6. [DOI: 10.1016/j.jhep.2013.12.027] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 7.8] [Reference Citation Analysis]
39 Cook L, Stahl M, Han X, Nazli A, MacDonald KN, Wong MQ, Tsai K, Dizzell S, Jacobson K, Bressler B, Kaushic C, Vallance BA, Steiner TS, Levings MK. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells. Gastroenterology 2019;157:1584-98. [PMID: 31513797 DOI: 10.1053/j.gastro.2019.09.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
40 Petrillo MG, Ronchetti S, Ricci E, Alunno A, Gerli R, Nocentini G, Riccardi C. GITR+ regulatory T cells in the treatment of autoimmune diseases. Autoimmun Rev 2015;14:117-26. [PMID: 25449679 DOI: 10.1016/j.autrev.2014.10.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
41 Hiratsuka T, Inomata M, Goto S, Oyama Y, Nakano T, Chen C, Shiraishi N, Noguchi T, Kitano S. Phototherapy with artificial light suppresses dextran sulfate sodium-induced colitis in a mouse model: Phototherapy on DSS colitis. J Gastroenterol Hepatol 2014;29:749-56. [DOI: 10.1111/jgh.12460] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
42 Ben Ya'acov A, Lichtenstein Y, Zolotarov L, Ilan Y. The gut microbiome as a target for regulatory T cell-based immunotherapy: induction of regulatory lymphocytes by oral administration of anti-LPS enriched colostrum alleviates immune mediated colitis. BMC Gastroenterol 2015;15:154. [PMID: 26518263 DOI: 10.1186/s12876-015-0388-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
43 Dasgupta S, Kasper DL. Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2478-2489. [PMID: 23846489 DOI: 10.1097/MIB.0b013e318297d884] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
44 You P, Chen N, Su L, Peng T, Chen G, Liu Y. Local level of TGF-β1 determines the effectiveness of dexamethasone through regulating the balance of Treg/Th17 cells in TNBS-induced mouse colitis. Exp Ther Med 2018;15:3639-49. [PMID: 29545894 DOI: 10.3892/etm.2018.5852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Földes A, Kádár K, Kerémi B, Zsembery Á, Gyires K, S Zádori Z, Varga G. Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage. Curr Neuropharmacol 2016;14:914-34. [PMID: 26791480 DOI: 10.2174/1570159x14666160121115210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
46 Nakakura S, Matsui M, Sato A, Ishii M, Endo K, Muragishi S, Murase M, Kito H, Niguma H, Kurokawa N, Fujii M, Araki M, Araki K, Ohya S. Pathophysiological significance of the two-pore domain K(+) channel K2P5.1 in splenic CD4(+)CD25(-) T cell subset from a chemically-induced murine inflammatory bowel disease model. Front Physiol 2015;6:299. [PMID: 26578971 DOI: 10.3389/fphys.2015.00299] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
47 Zaiatz Bittencourt V, Jones F, Doherty G, Ryan EJ. Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab024. [PMID: 33693743 DOI: 10.1093/ibd/izab024] [Reference Citation Analysis]
48 Li Y, Ma K, Zhang L, Xu H, Zhang N. Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells Alleviate Dextran Sulfate Sodium-Induced Colitis by Increasing Regulatory T Cells in Mice. Front Cell Dev Biol 2020;8:604021. [PMID: 33330503 DOI: 10.3389/fcell.2020.604021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
49 Gousopoulos E, Proulx ST, Bachmann SB, Scholl J, Dionyssiou D, Demiri E, Halin C, Dieterich LC, Detmar M. Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function. JCI Insight 2016;1:e89081. [PMID: 27734032 DOI: 10.1172/jci.insight.89081] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
50 Zeng H, Zhang R, Jin B, Chen L. Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance. Cell Mol Immunol 2015;12:566-71. [PMID: 26051475 DOI: 10.1038/cmi.2015.44] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 16.6] [Reference Citation Analysis]
51 Ismail RIH, Awad HA, Imam SS, Gad GI, Aboushady NM, Abdou RM, Eissa DS, Azzam NT, Barakat MM, Yassin MM, Barakat NM. Gut priming with bovine colostrum and T regulatory cells in preterm neonates: a randomized controlled trial. Pediatr Res 2021. [PMID: 33446924 DOI: 10.1038/s41390-020-01344-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Lv Y, Xu X, Zhang B, Zhou G, Li H, Du C, Han H, Wang H. Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice. J Transl Med. 2014;12:344. [PMID: 25475342 DOI: 10.1186/s12967-014-0344-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
53 Zhao HM, Huang XY, Zuo ZQ, Pan QH, Ao MY, Zhou F, Liu HN, Liu ZY, Liu DY. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice. World J Gastroenterol 2013; 19(5): 742-749 [PMID: 23430765 DOI: 10.3748/wjg.v19.i5.742] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
54 Yu L, Yang F, Zhang F, Guo D, Li L, Wang X, Liang T, Wang J, Cai Z, Jin H. CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production. Cell Death Dis 2018;9:905. [PMID: 30185773 DOI: 10.1038/s41419-018-0927-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
55 Yang J, Lim SY, Ko YS, Lee HY, Oh SW, Kim MG, Cho WY, Jo SK. Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease. Nephrology Dialysis Transplantation 2019;34:419-28. [DOI: 10.1093/ndt/gfy172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
56 Liu C, Li Y, Chen Y, Huang S, Wang X, Luo S, Su Y, Zhou L, Luo X. Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis. Mediators Inflamm 2020;2020:5918587. [PMID: 33082710 DOI: 10.1155/2020/5918587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Candia E, Reyes P, Covian C, Rodriguez F, Wainstein N, Morales J, Mosso C, Rosemblatt M, Fierro JA. Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells. PLoS One 2017;12:e0182009. [PMID: 28746369 DOI: 10.1371/journal.pone.0182009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
58 Ramos GP, Faubion WA, Papadakis KA. Targeting Specific Immunologic Pathways in Crohn's Disease. Gastroenterol Clin North Am 2017;46:577-88. [PMID: 28838416 DOI: 10.1016/j.gtc.2017.05.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Neurath MF, Leppkes M. Resolution of ulcerative colitis. Semin Immunopathol 2019;41:747-56. [DOI: 10.1007/s00281-019-00751-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
60 Brockmann L, Gagliani N, Steglich B, Giannou AD, Kempski J, Pelczar P, Geffken M, Mfarrej B, Huber F, Herkel J, Wan YY, Esplugues E, Battaglia M, Krebs CF, Flavell RA, Huber S. IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo. J Immunol 2017;198:1130-41. [PMID: 28003377 DOI: 10.4049/jimmunol.1601045] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 8.7] [Reference Citation Analysis]
61 Do JS, Visperas A, Sanogo YO, Bechtel JJ, Dvorina N, Kim S, Jang E, Stohlman SA, Shen B, Fairchild RL. An IL-27/Lag3 axis enhances Foxp3(+) regulatory T cell-suppressive function and therapeutic efficacy. Mucosal Immunol. 2016;9:137-145. [PMID: 26013006 DOI: 10.1038/mi.2015.45] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 7.6] [Reference Citation Analysis]
62 Kurosawa M, Nagai H. Accumulation of Mast Cells in the Lesions and Effects of Antiallergic Drugs on the Patients with Inflammatory Bowel Disease. Ulcers 2013;2013:1-7. [DOI: 10.1155/2013/714807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Qiu X, Zhang M, Yang X, Hong N, Yu C. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J Crohns Colitis 2013;7:e558-68. [PMID: 23643066 DOI: 10.1016/j.crohns.2013.04.002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 14.0] [Reference Citation Analysis]
64 Kowalska-Duplaga K, Kapusta P, Gosiewski T, Sroka-Oleksiak A, Ludwig-Słomczyńska AH, Wołkow PP, Fyderek K. Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn's Disease. J Clin Med 2020;9:E687. [PMID: 32143438 DOI: 10.3390/jcm9030687] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
65 van Herk EH, Te Velde AA. Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets. J Gastroenterol Hepatol 2016;31:1393-404. [PMID: 26990130 DOI: 10.1111/jgh.13342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
66 Chruscinski A, Sadozai H, Rojas-Luengas V, Bartczak A, Khattar R, Selzner N, Levy GA. Role of Regulatory T Cells (Treg) and the Treg Effector Molecule Fibrinogen-like Protein 2 in Alloimmunity and Autoimmunity. Rambam Maimonides Med J 2015;6. [PMID: 26241231 DOI: 10.5041/RMMJ.10209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
67 Luzentales-Simpson M, Pang YCF, Zhang A, Sousa JA, Sly LM. Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases. Front Cell Dev Biol 2021;9:612830. [PMID: 33614645 DOI: 10.3389/fcell.2021.612830] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Liao ZQ, Ji QF, Zhou BJ. Strategies for inflammatory bowel disease drug research by targeting gut microbiota. Shijie Huaren Xiaohua Zazhi 2020; 28(22): 1112-1120 [DOI: 10.11569/wcjd.v28.i22.1112] [Reference Citation Analysis]
69 Kotla NG, Rana S, Sivaraman G, Sunnapu O, Vemula PK, Pandit A, Rochev Y. Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives. Adv Drug Deliv Rev 2019;146:248-66. [PMID: 29966684 DOI: 10.1016/j.addr.2018.06.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
70 Mohammadnia-afrouzi M, Hosseini AZ, Khalili A, Abediankenari S, Amari A, Aghili B, Nataj HH. Altered microRNA Expression and Immunosuppressive Cytokine Production by Regulatory T Cells of Ulcerative Colitis Patients. Immunological Investigations 2015;45:63-74. [DOI: 10.3109/08820139.2015.1103749] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
71 Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn’s disease. Gastroenterology. 2012;143:1207-1217.e1-e2. [PMID: 22885333 DOI: 10.1053/j.gastro.2012.07.116] [Cited by in Crossref: 217] [Cited by in F6Publishing: 207] [Article Influence: 21.7] [Reference Citation Analysis]
72 Schoultz I, Keita ÅV. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Cells 2019;8:E193. [PMID: 30813280 DOI: 10.3390/cells8020193] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 17.0] [Reference Citation Analysis]
73 Soltanzadeh-yamchi M, Shahbazi M, Aslani S, Mohammadnia-afrouzi M. MicroRNA signature of regulatory T cells in health and autoimmunity. Biomedicine & Pharmacotherapy 2018;100:316-23. [DOI: 10.1016/j.biopha.2018.02.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
74 Zhang M, Zhou L, Zhang S, Yang Y, Xu L, Hua Z, Zou X. Bifidobacterium longum affects the methylation level of forkhead box P3 promoter in 2, 4, 6-trinitrobenzenesulphonic acid induced colitis in rats. Microb Pathog 2017;110:426-30. [PMID: 28733028 DOI: 10.1016/j.micpath.2017.07.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
75 Jones-Hall YL, Nakatsu CH. The Intersection of TNF, IBD and the Microbiome. Gut Microbes. 2016;7:58-62. [PMID: 26939853 DOI: 10.1080/19490976.2015.1121364] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
76 An JH, Song WJ, Li Q, Kim SM, Yang JI, Ryu MO, Nam AR, Bhang DH, Jung YC, Youn HY. Prostaglandin E2 secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice. BMC Vet Res 2018;14:354. [PMID: 30453939 DOI: 10.1186/s12917-018-1684-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
77 Pesenacker AM, Broady R, Levings MK. Control of tissue-localized immune responses by human regulatory T cells. Eur J Immunol. 2015;45:333-343. [PMID: 25378065 DOI: 10.1002/eji.201344205] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
78 Li J, Ueno A, Fort Gasia M, Luider J, Wang T, Hirota C, Jijon HB, Deane M, Tom M, Chan R, Barkema HW, Beck PL, Kaplan GG, Panaccione R, Qian J, Iacucci M, Gui X, Ghosh S. Profiles of lamina propria T helper cell subsets discriminate between ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2016;22:1779-1792. [PMID: 27243594 DOI: 10.1097/mib.0000000000000811] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]